Log In
Print this Print this

Ventana ALK (D5F3) CDx Assay

Also known as: Ventana ALK (D5F3) Rabbit Monoclonal Primary Antibody assay

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionAutomated immunohistochemistry (IHC) test
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetecting HER protein expression in cancer patients who may be candidates for Kadcyla ado-trastuzumab emtansine (T-DM1), Perjeta pertuzumab or Herceptin trastuzumab treatment; To identify anaplastic lymphoma kinase (ALK)-positive patients among non-small cell lung cancer (NSCLC) patients
Regulatory Designation
PartnerCell Signaling Technology Inc.;
Pfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today